Zenas BioPharma Secures $118 Million to Advance its Broad Pipeline of Autoimmune Disease Therapeutics

Monday, November 7, 2022 1 min read

Key Takeaway: Zenas BioPharma Secures $118 Million to Advance its Broad Pipeline of Autoimmune Disease Therapeutics

Full Press Release Details

Zenas BioPharma Secures $118 Million to Advance its Broad Pipeline of Autoimmune Disease Therapeutics.